AMA format . In your annotations address the following: i. Which agency/organization developed the guideline, and date of the guideline. ii. What are the clinical goals of the guideline? (i.e. prevent CVD, delay renal failure) iii. What comorbidities are addressed if any? iv. What is the quality or level of evidence of the guideline? v. Was it based on a consensus of experts or on a careful meta-analysis of the latest research or something in between? vi. Are there specific recommendations that address implementation of each aspect of the Chronic Care Model in your clinical setting? For example, in addition to medication management, which aspects of the Chronic Care Model are addressed (self-management, decision support systems, delivery system design, clinical information management, health care organizations, and community resources)? vii. What are the most useful aspects of this guideline?
